Skip to main content
. Author manuscript; available in PMC: 2018 Sep 13.
Published in final edited form as: Cerebellum. 2018 Oct;17(5):507–516. doi: 10.1007/s12311-018-0933-6

Table 1.

Demographics and clinical characteristics of HC and CSU groups. Values are presented as mean ± SD.

HC (n=40) CSU group (n=40) CSU group completed the intervention (n=32)
Gender (male/female) 8/32 8/32 6/26
Age (year) 42.6 ± 10.8 42.6 ± 10.8 43.6 ± 11.6
Duration of illness (month) 103 ± 150 109 ± 158
UAS7 30.8 ± 6.2 30.2 ± 6.1(pre) 19.5 ± 7.3(post)